chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received Influenza vaccine on 10/1.  Started on Wednesday evening  10/2 having body aches and fatigue, about 6-7PM.  Thursday morning throat scratchy and tired and achy all day and nauseated.  Friday, 10/4 Throat sore and achy in chest and coughing, body aches and congested.  Saturday, temp 99.8, 100.2 in evening and Sunday same symptoms.  Monday nose is congested.  Still not feeling well.  Has been taking Ibuprofen.
Patients guardian reported a rash that appeared 4 days after immunization encounter, rash first appeared on torso and the spread to arms and legs/ pt did not report any itching along with patients rash.
Information has been received from a physician concerning a male who was vaccinated with the first dose of Rotateq. The physician reported that the patient subsequently developed diarrhea. It was unknown if medical attention was sought. At the time of this report, the outcome was unknown. It was noted that the patient was discontinued from the series. This is one of several reports from the same source. Additional information has been requested.
Shortly following injection, the patient complained of chest tightness, itchy throat, and mild erythema of the skin with pruritus.  Serial vital signs were monitored for almost 2 hours and were stable. She was in no acute distress.  8 mg of dexamethasone was administered with improvement of her symptoms.
Pt received Dtap vaccine (R) arm 5/11/07 should have been given tdap. Pt seen in clinic today 0930 with localized redness and swelling (65cm x 70cm) at injection site. No anaphylaxis reported or noted. Pt instructed to take Ibuprofen Q 4 hours x 24 hours 2x day. and alternate ice packs with warm packs until redness/swelling subside.
Patient called to report severe pain in the arm following the administration of the vaccination.  "It hurts really bad, I haven't been able to lift it to hold my cell phone or drive for the last two weeks."
Woke up this AM with headache and achy flu-like symptoms. Fever 100.5 denies nausea/vomiting. Took Advil, to see FMD.
Within 24 hours there was fatigue throughout my left arm. 36 hours after the vaccination, fatigue and weakness had spread to my entire body. 4 days after the vaccination, I collapsed in an urgent care because my legs were unable to support my body weight. I was moved to an examination table by the staff where I lost my ability to move my arms and legs, experienced labored breathing, full body tingling, and loss of control of my facial muscles. The urgent care called 911 and I was transported to Hospital. Discharged me a few hours later after symptoms had subsided, but not disappeared entirely. The following day, 04/15/2021, I saw my primary care physician, I was unable to sit up myself while on his examination table and he sent me to Hospital in. Upon arriving at Hospital, I was given several neurological exams, all of which did not yield any diagnostic results. I was admitted to the hospital for further testing and observation. It was at this time that my ability to walk was severely diminished and the PTs in the hospital had observed that I was unable to walk steadily and was unable to navigate stairs. My fine motor control also was diminished to the point that I was unable to cut my own food. Upon diagnosis of the B12 deficiency on 04/22/2021, I was discharged to the Rehab center at Hospital. After a weeklong stay and the regaining of my physical mobility and ambulation, I was discharged from the Rehab at Hospital. I continued PT, as well as B12 oral supplements, in an outpatient setting until I was independent enough to function myself, on 06/10/2021, and continued the at home exercises they recommended. On 7/09/2021 I began to feel lingering feelings of fatigue and weakness again, at first isolated to that day. On 7/18 I felt more fatigue and weakness. I went to the ER at hospital again on 7/22 as I was unable to lift myself out of bed that morning and was experiencing elevated levels of fatigue and weakness. Upon being readmitted, they began to run more tests, but the results were undiagnostic. All doctors were in agreement that the vaccine had some kind of affect but were unable to pin down how or why as the timeframe from walking around with no issues, and then this extended illness being onset within 24 hours of the shot was too close in temporal proximity to ignore or discount. I was eventually diagnosed with chronic fatigue syndrome and discharged Rehabilitation Facility on 08/09/2021 where I stayed for 16 days to remedy some of the muscle atrophy that occurred as a result of the extended 19 day stay in hospital.
I felt really tired that evening of the vaccine. For the next several days my body ached and my head hurt especially when I stood up.   This slowly went away after a week.
Patient developed a headache the evening of 9/25 immediately following her vaccines. She woke up today, 9/26 @ 6am to get ready for school. Around 6:15 am, she said that she wasn't feeling well and thought she needed to vomit. She ran for the bathroom and collapsed on the way. The fainting spell lasted approx. 30 seconds - eyes rolled back, muscles twitching.  She didn't remember anything about it once she came to. She was coherent immediately following the event.
4/29/09 - Rt arm inflamed and swollen from shoulder to elbow - no pain, no fever - when picked up from day care. 4/30/09 - Arm unchanged - still no pain or fever. Seeing Dr. 5/1/09 - mother will call if any concerns or abnormal findings.
Initial unsolicited report received from a pharmacist via other company (Pfizer under reference number 2016020143) on 20 January 2016. This case involves a 74-year-old female patient had received a dose of INFLUENZA VACCINE (UNSPECIFIED FLU SHOT) (batch number, route and site of administration not reported) and also received 0.5 ml dose of PREVNAR 13 (batch number M13067, expiry date April 2017, route and site of administration not reported) on 4 January 2016. The patient's medical history was reported as the patient was healthy and did not had any other medical conditions. The patient receives a flu shot almost every year and concomitant medications were not reported. On an unspecified date about 4 days after the vaccination the patient developed a rash on the arm and also had temperature and bad reaction. Laboratory investigations was reported as none. The patient had received steroid, dose pack of prednisone as corrective treatments At the time of this report the patient outcome was temperature lasted for few days and was not reported for other events. Causality of event rash was reported as related to vaccine. Documents held by sender: none.
About 4-5 days after vaccine administration woke up with swollen lymph nodes in left axillary. Swollen, tender, painful. Lasting into the next day. Remain swollen, tender and painful. Periodic burning sensation. Have used warm compress, tylenol, ibuprofen, hydration. As today is the second day with symptoms I am reporting because it has not yet eased up.
Shortly after that, I had flu symptoms, aching; Shortly after that, I had flu symptoms, aching; I was weak, couldn't nagivate; I had to stay in bed for days, I was so sick; She subsequently experienced my arm got swollen, huge; Two shots, five days apart; Two shots, five days apart; This past winter I had the flu and pneumonia twice; This past winter I had the flu and pneumonia twice; The injection site was sore; This spontaneous report was received from a currently 85 year-old female patient regarding herself. The patient  concurrent conditions included blood pressure abnormal and had no pertinent medical history, drug reactions, and allergies. The patient's concomitant therapies included blood pressure pill.  On unspecified date (reported as 20 years ago  or more), the patient was vaccinated Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) 2 injections (reported as 2 shots) (extra dose administered) five days apart (inappropriate schedule of product administration) for pneumonia (lot number, and expiration date were not reported).   Shortly after she subsequently experienced that her arm got swollen, huge (injection site swelling). Shortly after that, she had flu symptoms(influenza), aching (pain). She stated, she was weak, and could not navigate (asthenia). She had to stay in bed for days, she was so sick (malaise). The injection site was sore (injection site pain). It was reported that the patient recovered on unspecified date (reported as a week later) of the events injection site swelling, influenza, pain, asthenia, malaise, and injection site pain. Then, in 2018 (reported as the past winter), she had the flu (influenza) and pneumonia twice in 18 months. The patient talked to the doctor, and no laboratories and studied were performed.    The outcome of the events influenza and pneumonia was not provided.   The causal relationship between the aforementioned events and vaccine Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23)  was not provided.   Upon internal review, the event pneumonia was considered to be medically significant.
Right arm swelled from elbow down to hand. Did not have swelling above the elbow. Red. Patient went to emergency room and received doxycycline hyclate 100mg once daily for 10 days.  Fully resolved, recovering well.
felt sick for 8 days; Very Dizzy; Hot to the touch Injection Site; Redness Injection Site bigger 3" diameter; Swollen Injection Site; Hurts Injection Site Red Area; Itching Injection Site; Tired and Fatigue; Chills (No Fever); Headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt sick for 8 days), DIZZINESS (Very Dizzy), INJECTION SITE WARMTH (Hot to the touch Injection Site), FATIGUE (Tired and Fatigue) and CHILLS (Chills (No Fever)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Tired and Fatigue), CHILLS (Chills (No Fever)) and HEADACHE (Headache). On 07-Mar-2021, the patient experienced DIZZINESS (Very Dizzy), INJECTION SITE WARMTH (Hot to the touch Injection Site), INJECTION SITE ERYTHEMA (Redness Injection Site bigger 3" diameter), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE PAIN (Hurts Injection Site Red Area) and INJECTION SITE PRURITUS (Itching Injection Site). On an unknown date, the patient experienced ILLNESS (felt sick for 8 days). On 27-Feb-2021, CHILLS (Chills (No Fever)) and HEADACHE (Headache) had resolved. On 28-Feb-2021, FATIGUE (Tired and Fatigue) had resolved. At the time of the report, ILLNESS (felt sick for 8 days) had resolved and DIZZINESS (Very Dizzy), INJECTION SITE WARMTH (Hot to the touch Injection Site), INJECTION SITE ERYTHEMA (Redness Injection Site bigger 3" diameter), INJECTION SITE SWELLING (Swollen Injection Site), INJECTION SITE PAIN (Hurts Injection Site Red Area) and INJECTION SITE PRURITUS (Itching Injection Site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided by reporter.  Per report, after receiving the first dose of the covid-19 vaccine in 26-FEB-2021, the patient felt sick for 8 days, which she attributed to a delayed site reaction.   This case was linked to MOD-2021-252892.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: 2nd Dose information is updated
Subsequent to receiving the vaccine, pt developed injection site pain described as tender, and she developed severely decreased range of motion in her arm. She was seen by the employee physician.
On 12/06/22 I started having symptoms of excessive bowel movements, no pain just urgency, no control, I went to my doctor and had a stool sample and tested positive for C-diff, I was given medication an antibiotic, vancomycin to help get rid of the bacteria that was causing the C-diff. I took the antibiotic for 10 days, everything cleared within 3 to 4 days after I started taking the medication. My stomach is sensitive even now.
THE NIGHT OF THE VACCINE CLIENT EXPERIENCE HEADACHE. CHILLS, FEVER  (NO QUANTIFY). NEXT DAY HAD RASH  WITH ITCHY THAT STARTED  ON NECK AND EXTENDED TO THE CHEST, SIDES/ TORSO, INSIDE OF LEGS. VERY SORE ARM ON THE SIDE OF THE INJECTION.
Strong and varied headaches, mostly occurring at night, but throughout the day as well. Not localized, but move around the head, strong enough to wake up at night.
Individual reported that she felt warm soon after vaccine was administered.  She quickly asked to lay down and feet were raised and she was given something sweet to drink.  Individual reported that she had slept in and had not eaten that morning.  VS at 12:27  - BP 152/72. P 115 and pulse oximeter - 99%.  12:35 - BP 148/80 and individual sitting in chair.  She reported feeling better.  Staff called husband to come and pick up.  Individual waited at clinic site for 30-45 minutes for her husband and no additional complaints.
palpitations in her heart; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 46-years-old female patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: unknown), via an unknown route of administration on an unknown date in Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medication were not reported. She received the first dose of the Pfizer-BioNTech COVID-19 Vaccine in Mar2021 and did not go for the second dose because after about 2 days she had palpitations in her heart. She had some cardiology work to check if everything was okay. She also asked her doctor for second dose and was advised to get the second dose. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not available and will be requested during follow up.
She developed bronchitis and pneumonia, heart irregularities within 5 days of injection-she was put on lots of medications and has gotten down to current therapy of amlodipine 2.5mg and amiodarone 100mg daily, ELIQUIS 2.5 mg bid-has frequent episodes of low blood pressure, dizziness, weakness.
Information per Dr.'s dictation. Flu shot given on 9/24/2013 - felt pain severe when she was given the injection and the pain kind of shot down her arm into her fingers. Stated sore for a few days, but it persisted and she became concerned when pain did not go away. She states that she does get intermittent numbness and tinling in arm. Denies chills, fever, nausea or vomiting no redness swelling after shot. Taking Ibuprofen and will f/u with ortho if needed.
Initial miuse report received from a healthcare professional on 20 January 2014. 2014 and the case was received on 21 March 2014 at GPV. A '04-year-old' patient (No information was provided regarding the patient) had received second dose of FLUZONE 0.25 ml, and first dose of FLUZONE 0.5 ml on an unspecified date i.e. Underdose. No adverse event was reported. List of documents held by sender: none.
Left arm red, hurts when you touch. 1:00pm 10/4/17. From flu vaccine administered by employer 10/4/17
I have had severely worsened anxiety; I have had severely worsened anxiety, new panic attacks Ive never had before,; Daily headaches; Waves of extreme fatigue; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 18:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and depression. The patient did not have any allergies to medications, food, or other products. Concomitant medications included oral birth control nos (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 18Mar2021, the patient experienced severely worsened anxiety, new panic attacks she had never had before, daily headaches, and waves of extreme fatigue. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events anxiety, panic attacks, headaches and fatigue was not resolved/ongoing at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 18:30 (at the age of 24-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
very itchy; Rash around injection site; It's not extreme red as like yesterday; A spontaneous report was received from a Consumer, concerning a 43-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash around injection site, very itchy, it's not extreme red as like yesterday.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 027L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 28 Jan 2021, the patient experienced rash around injection site, very itchy, it's not extreme red as like yesterday.  Treatment details included Cortisone cream.  Action taken with mRNA-1273 in response to the events was not reported.   Outcome of events, rash around injection site, very itchy and it's not extreme red as like yesterday was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
This spontaneous report was received from a registered nurse referring to multiple unspecified patients (age and gender unknown). No information regarding the patients' concurrent conditions, medical history, drug reactions or allergies, and concomitant therapies was provided. The reporter stated that, on unspecified dates, the patients were vaccinated with improperly stored doses (incorrect product storage) of injectable PROQUAD (lot# L042818, expiration date 26-APR-2017; lot# M011664, expiration date 08-SEP-2017; and lot# M004889, expiration date 25-JUL-2017), subcutaneously for prophylaxis (strength, dose, frequency, albumin status and anatomical location were not reported). The vaccine doses were exposed to a temperature excursion of 19.4 Fahrenheit degrees in a time frame of 3 hours and 45 minutes; digital data logger was involved and previous temperature excursion was confirmed. No adverse effects were reported. Reportedly, the vaccine doses were reconstituted with properly stored diluent MRK (lot number and expiration date were unknown). There was no product quality complain (PQC) reported. This is one of three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA002390: US-009507513-1704USA002389.
1/6/21. c/o rt shoulder redness, bump, burning  sensation to rt arm, limited ROM of rt arm. to send ED for evaluation
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. The patients' pertinent medical history, drug reactions and allergies were not reported. On 23-SEP-2016, the patient was vaccinated with (Oka/Merck) PROQUAD lot # L047305, expiry date: 23-MAY-2017 and (Oka/Merck) VARIVAX, lot # L000455, expiry date: 06-JAN-2017 (dose and route was not reported for both vaccines) during the same office visit (Inappropriate schedule of drug administration). No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
This spontaneous report was received from a healthcare worker concerning an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On an unknown date, the unspecified patients were vaccinated with improperly stored doses of RECOMBIVAX HB (dose, dose number, route, anatomical location, lot number and expiration date were unspecified). No adverse effects reported. Concomitant therapies were not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Expired vaccine was kept in refrigerator; No adverse event; Vaccine expired on 20-May-2022/Patient received vaccine on 16-Jun-2022; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022/Patient received vaccine on 16-Jun-2022), PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator) and NO ADVERSE EVENT (No adverse event) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033K21-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022/Patient received vaccine on 16-Jun-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022/Patient received vaccine on 16-Jun-2022), PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 20-May-2022/Patient received vaccine on 16-Jun-2022) and PRODUCT STORAGE ERROR (Expired vaccine was kept in refrigerator).    No concomitant medications were reported.  The patient had received second booster dose. Number of doses/vials were 7 doses/1 vial. The vial did not undergo any temperature excursions. The Healthcare Professional (HCP) did not know the date the vial was initially stored in the refrigerator but stated that vaccines were usually put in refrigerator a week before administration. Patient had not reported any adverse reactions. No treatment details were reported.